Top Markets
Coin of the day
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Peringkat dalam Saham #25183
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Harga Saham
$1.95
Terakhir disinkronkan: 2022-07-29
Kapitalisasi Pasar
$52.48M
Perubahan (1 hari)
2.63%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Cortexyme, Inc. (CRTX)

Kategori

Riwayat harga saham Cortexyme, Inc. (CRTX)
Harga penutupan tertinggi: $2.18 pada 2022-07-01

Harga penutupan terendah: $26.37 pada 2019-05-01
Riwayat harga saham Cortexyme, Inc. dari 2019 hingga 2026
Performa harga saham tahunan
Tahun Performa
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$761.87 8.65%
CH
$130.43 397.46%
US